特一药业
(002728)
| 流通市值：33.05亿 | | | 总市值：45.01亿 |
| 流通股本：3.76亿 | | | 总股本：5.13亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 286,258,083.96 | 230,161,408.15 | 457,414,315.11 | 384,881,891.18 |
| 交易性金融资产 | 75,000,000 | 50,000,000 | - | 215,000,000 |
| 应收票据及应收账款 | 139,559,816.8 | 188,394,058.76 | 205,321,950.87 | 132,792,589.38 |
| 其中：应收票据 | 71,589,420.53 | 98,367,204.92 | 106,575,601.48 | 57,018,214.01 |
| 应收账款 | 67,970,396.27 | 90,026,853.84 | 98,746,349.39 | 75,774,375.37 |
| 预付款项 | 19,695,486.14 | 25,992,347.79 | 10,403,104.32 | 18,044,961.85 |
| 其他应收款合计 | 1,211,196.25 | 1,395,952.73 | 9,375,183 | 1,301,281.88 |
| 其中:应收利息 | - | 295,136.99 | 458,221.92 | 686,950.68 |
| 存货 | 286,205,647.15 | 275,775,649.5 | 264,377,722.25 | 291,610,818.03 |
| 其他流动资产 | 8,628,164.78 | 5,896,657.4 | 4,054,787.91 | 4,042,666.26 |
| 流动资产合计 | 816,558,395.08 | 777,616,074.33 | 950,947,063.46 | 1,047,674,208.58 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 13,500,000 | 13,500,000 | 13,500,000 | 13,500,000 |
| 投资性房地产 | 8,898,818.19 | 7,708,905.96 | 9,141,872.07 | 9,263,429.84 |
| 固定资产 | 541,588,272.18 | 553,286,470.76 | 563,512,848.94 | 511,450,406.18 |
| 在建工程 | 184,645,723.95 | 157,131,390.58 | 157,882,304.69 | 173,744,602.18 |
| 无形资产 | 139,074,849.07 | 135,532,941.17 | 138,631,569.26 | 141,768,334.79 |
| 开发支出 | 16,551,926.44 | 21,172,691.72 | 17,407,880.4 | 14,688,155.11 |
| 商誉 | 517,600,671.3 | 517,600,671.3 | 517,600,671.3 | 529,228,239.78 |
| 递延所得税资产 | 18,713,397.13 | 23,904,996.05 | 21,852,750.97 | 26,442,193.45 |
| 其他非流动资产 | 17,634,065.85 | 14,459,458.18 | 10,398,863.1 | 23,510,789.91 |
| 非流动资产合计 | 1,458,207,724.11 | 1,444,297,525.72 | 1,449,928,760.73 | 1,443,596,151.24 |
| 资产总计 | 2,274,766,119.19 | 2,221,913,600.05 | 2,400,875,824.19 | 2,491,270,359.82 |
| 流动负债: | | | | |
| 短期借款 | 310,000,000 | 260,000,000 | 516,093,372.63 | 640,000,000 |
| 应付票据及应付账款 | 86,892,756.98 | 69,655,777.56 | 44,827,936.52 | 40,997,605.88 |
| 其中：应付票据 | 15,839,387.42 | 8,679,364.5 | 10,325,108.2 | 16,652,690.65 |
| 应付账款 | 71,053,369.56 | 60,976,413.06 | 34,502,828.32 | 24,344,915.23 |
| 合同负债 | 21,105,271.52 | 26,758,633.23 | 11,049,015.76 | 15,508,414.42 |
| 应付职工薪酬 | 7,279,460.67 | 7,996,672.75 | 9,408,041.89 | 5,845,424.79 |
| 应交税费 | 6,996,508.76 | 13,433,047.48 | 10,422,298.29 | 8,061,342.31 |
| 其他应付款合计 | 28,236,395.48 | 3,082,098.48 | 2,788,875.22 | 2,755,652.83 |
| 应付股利 | 24,946,612.4 | - | - | - |
| 其他流动负债 | 2,737,513.06 | 3,478,622.32 | 1,429,209.52 | 2,016,093.88 |
| 流动负债合计 | 463,247,906.47 | 384,404,851.82 | 596,018,749.83 | 715,184,534.11 |
| 非流动负债: | | | | |
| 递延收益 | 18,897,894.07 | 19,750,133.4 | 20,568,580.93 | 19,307,520.95 |
| 递延所得税负债 | 19,209,390.4 | 19,278,646.88 | 19,355,254.86 | 15,184,111.29 |
| 非流动负债合计 | 38,107,284.47 | 39,028,780.28 | 39,923,835.79 | 34,491,632.24 |
| 负债合计 | 501,355,190.94 | 423,433,632.1 | 635,942,585.62 | 749,676,166.35 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 512,625,018 | 512,531,525 | 512,210,211 | 510,700,274 |
| 资本公积 | 846,299,636.22 | 845,809,732.9 | 844,126,047.54 | 836,879,220.77 |
| 减:库存股 | 101,192,257.35 | 93,947,845.02 | 93,856,250.88 | 93,856,250.88 |
| 专项储备 | 6,814,059.74 | 6,715,927.26 | 6,649,876.75 | 6,552,798.49 |
| 盈余公积 | 142,309,314.62 | 142,309,314.62 | 142,309,314.62 | 140,177,741.96 |
| 未分配利润 | 366,555,157.02 | 385,061,313.19 | 353,494,039.54 | 341,140,409.13 |
| 归属于母公司股东权益合计 | 1,773,410,928.25 | 1,798,479,967.95 | 1,764,933,238.57 | 1,741,594,193.47 |
| 股东权益合计 | 1,773,410,928.25 | 1,798,479,967.95 | 1,764,933,238.57 | 1,741,594,193.47 |
| 负债和股东权益合计 | 2,274,766,119.19 | 2,221,913,600.05 | 2,400,875,824.19 | 2,491,270,359.82 |
| 公告日期 | 2025-08-22 | 2025-04-26 | 2025-04-26 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |